Jupiter, Florida–(Newsfile Corp. – December 2, 2025) – Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial dysfunction, today announced that its management team will present at the upcoming Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on …
Read More »
Breaking News
- Lions Clubs International to Host Global Advocacy Events for Lions Day with the United Nations
- Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease
- Excellon Announces Closing of Bought Deal Private Placement and Concurrent Private Placement for Gross Proceeds of Approximately C$21.8 Million
- Cascade Copper Corp. Presents in Existing Agency’s Virtual Webinar Series
- Brasnova Energy Materials Inc. Appoints Qualified Person and Initiates Sampling Program on the Capela Gold Project, Brazil
- Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
- AITX’s RAD Announces New Orders Reflecting Ongoing Market Demand
- Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
- Spin.AI Ranks in Forbes America’s Best Startup Employers for Third Consecutive Year
- West Coast Silver Ltd. Presents in Red Cloud’s Virtual Webinar Series
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar